Trial to test the effectiveness of biologic drug Inj. Adalimumab for the management of primary osteoarthritis of knee joint and to compare its effectiveness with Intra-articular Triamcinolone.
Phase 3
- Conditions
- Health Condition 1: M170- Bilateral primary osteoarthritis of knee
- Registration Number
- CTRI/2024/04/065428
- Lead Sponsor
- IPGMER and SSKM hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Satisfying ACR criteria for classification and reporting of osteoarthritis of knee joint, 1986
Age 40-75 years
Symptomatic for at-least 6 months
Radiographic Kellgren-Lawrence grade II (definite osteophyte and unimpaired joint space) or grade III (moderate multiple osteophytes, definite narrowing of joint space, some sclerosis and possible deformity of bone contour)
Visual analog score for knee pain at-least 40 or more on the scale of 0-100
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method